
Novo Nordisk Expands Wegovy Subscriptions to Hims, LifeMD, and Other Platforms
Novo Nordisk has introduced multi-month subscription plans for its obesity drug, Wegovy, offering lower monthly pricing and expanding sales channels to include platforms like Hims and LifeMD to compete with rivals.